• Japanese
  • Korean
  • Chinese
Cover Image

CSF Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Abstract

CSF Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Summary

GlobalData's new report, "CSF Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" provides key market data on the CSF Management market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment within two market categories -Dura Substitutes and Hydrocephalus Shunts. The report also provides company shares and distribution shares data for the overall CSF Management market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older-a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

  • Market size data for CSF Management market categories - Dura Substitutes and Hydrocephalus Shunts.
  • Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments within the two market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.
  • 2011 company shares and distribution shares data for the overall CSF Management market in each of the aforementioned countries.
  • Global corporate-level profiles of key companies operating within the CSF Management market in BRICS.
  • Key players covered include Medtronic, Inc., DePuy, Inc., B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Sophysa S.A., Christoph Miethke GmbH & Co. KG and G. Surgiwear Limited.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the CSF Management competitive landscape in BRICS.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

TOC

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Introduction 11

  • 2.1 What is This Report About? 11

3 CSF Management in BRICS 12

  • 3.1 CSF Management, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 12
  • 3.2 CSF Management, BRICS, Company share (2010-2011) 17

4 CSF Management In Brazil 19

  • 4.1 CSF Management, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 19
  • 4.2 Hydrocephalus Shunts In Brazil 24
    • 4.2.1 Hydrocephalus Shunts, Brazil, Overall Revenue (2004-2018) 24
    • 4.2.2 Hydrocephalus Shunts, Brazil, Overall Volume (2004-2018) 26
    • 4.2.3 Hydrocephalus Shunts, Brazil, Average Price (2004-2018) 28
  • 4.3 Dura Substitutes In Brazil 29
    • 4.3.1 Dura Substitutes, Brazil, Overall Revenue (2004-2018) 29
    • 4.3.2 Dura Substitutes, Brazil, Overall Volume (2004-2018) 31
    • 4.3.3 Dura Substitutes, Brazil, Average Price (2004-2018) 33
  • 4.4 CSF Management, Brazil, Distribution Share (2010-2011) 34
  • 4.5 CSF Management, Brazil, Company Share (2010-2011) 35

5 CSF Management In Russian Federation 37

  • 5.1 CSF Management, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 37
  • 5.2 Hydrocephalus Shunts In Russian Federation 42
    • 5.2.1 Hydrocephalus Shunts, Russian Federation, Overall Revenue (2004-2018) 42
    • 5.2.2 Hydrocephalus Shunts, Russian Federation, Overall Volume (2004-2018) 45
    • 5.2.3 Hydrocephalus Shunts, Russian Federation, Average Price (2004-2018) 47
  • 5.3 Dura Substitutes In Russian Federation 48
    • 5.3.1 Dura Substitutes, Russian Federation, Overall Revenue (2004-2018) 48
    • 5.3.2 Dura Substitutes, Russian Federation, Overall Volume (2004-2018) 50
    • 5.3.3 Dura Substitutes, Russian Federation, Average Price (2004-2018) 52
  • 5.4 CSF Management, Russian Federation, Distribution Share (2010-2011) 53
  • 5.5 CSF Management, Russian Federation, Company Share (2010-2011) 54

6 CSF Management In India 56

  • 6.1 CSF Management, India, Overall Revenue ($m), USD Constant, 2004-2018 56
  • 6.2 Hydrocephalus Shunts In India 61
    • 6.2.1 Hydrocephalus Shunts, India, Overall Revenue (2004-2018) 61
    • 6.2.2 Hydrocephalus Shunts, India, Overall Volume (2004-2018) 63
    • 6.2.3 Hydrocephalus Shunts, India, Average Price (2004-2018) 65
  • 6.3 Dura Substitutes In India 66
    • 6.3.1 Dura Substitutes, India, Overall Revenue (2004-2018) 66
    • 6.3.2 Dura Substitutes, India, Overall Volume (2004-2018) 68
    • 6.3.3 Dura Substitutes, India, Average Price (2004-2018) 70
  • 6.4 CSF Management, India, Distribution Share (2010-2011) 71
  • 6.5 CSF Management, India, Company Share (2010-2011) 72

7 CSF Management In China 74

  • 7.1 CSF Management, China, Overall Revenue ($m), USD Constant, 2004-2018 74
  • 7.2 Dura Substitutes In China 79
    • 7.2.1 Dura Substitutes, China, Overall Revenue (2004-2018) 79
    • 7.2.2 Dura Substitutes, China, Overall Volume (2004-2018) 81
    • 7.2.3 Dura Substitutes, China, Average Price (2004-2018) 83
  • 7.3 Hydrocephalus Shunts In China 84
    • 7.3.1 Hydrocephalus Shunts, China, Overall Revenue (2004-2018) 84
    • 7.3.2 Hydrocephalus Shunts, China, Overall Volume (2004-2018) 86
    • 7.3.3 Hydrocephalus Shunts, China, Average Price (2004-2018) 88
  • 7.4 CSF Management, China, Distribution Share (2010-2011) 89
  • 7.5 CSF Management, China, Company Share (2010-2011) 90

8 CSF Management In South Africa 92

  • 8.1 CSF Management, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 92
  • 8.2 Hydrocephalus Shunts In South Africa 97
    • 8.2.1 Hydrocephalus Shunts, South Africa, Overall Revenue (2004-2018) 97
    • 8.2.2 Hydrocephalus Shunts, South Africa, Overall Volume (2004-2018) 99
    • 8.2.3 Hydrocephalus Shunts, South Africa, Average Price (2004-2018) 101
  • 8.3 Dura Substitutes In South Africa 102
    • 8.3.1 Dura Substitutes, South Africa, Overall Revenue (2004-2018) 102
    • 8.3.2 Dura Substitutes, South Africa, Overall Volume (2004-2018) 104
    • 8.3.3 Dura Substitutes, South Africa, Average Price (2004-2018) 106
  • 8.4 CSF Management, South Africa, Distribution Share (2010-2011) 107
  • 8.5 CSF Management, South Africa, Company Share (2010-2011) 108

9 Overview of Key Companies in BRICS CSF Management Market 109

  • 9.1 Medtronic, Inc. 109
    • 9.1.1 Company Overview 109
    • 9.1.2 Share in the BRICS CSF Management Market 110
  • 9.2 DePuy, Inc. 111
    • 9.2.1 Company Overview 111
    • 9.2.2 Share in the BRICS CSF Management Market 112
  • 9.3 B. Braun Melsungen AG 113
    • 9.3.1 Company Overview 113
    • 9.3.2 Share in the BRICS CSF Management Market 114
  • 9.4 Integra LifeSciences Holdings Corporation 115
    • 9.4.1 Company Overview 115
    • 9.4.2 Share in the BRICS CSF Management Market 116
  • 9.5 Sophysa S.A. 117
    • 9.5.1 Company Overview 117
    • 9.5.2 Share in the BRICS CSF Management Market 118
  • 9.6 Christoph Miethke GmbH & Co. KG 119
    • 9.6.1 Company Overview 119
    • 9.6.2 Share in the BRICS CSF Management Market 120
  • 9.7 G. Surgiwear Limited 121
    • 9.7.1 Company Overview 121

10 Appendix 122

  • 10.1 Definitions of Markets Covered in the Report 123
    • 10.1.1 CSF Management 123
  • 10.2 Research Methodology 124
  • 10.3 Secondary Research 124
  • 10.4 Primary Research 125
  • 10.5 Models 125
  • 10.6 Forecasts 126
  • 10.7 Expert Panels 126
  • 10.8 GlobalData Consulting 126
  • 10.9 Currency Conversion 127
  • 10.10 Contact Us 127
  • 10.11 Disclaimer 127

List of Tables

1.1 List of Tables

  • Table 1: CSF Management, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 12
  • Table 2: CSF Management, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 14
  • Table 3: CSF Management, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 16
  • Table 4: CSF Management, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011 18
  • Table 5: CSF Management, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 19
  • Table 6: CSF Management, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 21
  • Table 7: CSF Management, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 23
  • Table 8: Hydrocephalus Shunts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 24
  • Table 9: Hydrocephalus Shunts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 25
  • Table 10: Hydrocephalus Shunts, Brazil, Volume (Units), Historic, 2004-2011 26
  • Table 11: Hydrocephalus Shunts, Brazil, Volume (Units), Forecast, 2011-2018 27
  • Table 12: Hydrocephalus Shunts, Brazil, Average Price ($), Historic, 2004-2011 28
  • Table 13: Hydrocephalus Shunts, Brazil, Average Price ($), Forecast, 2011-2018 28
  • Table 14: Dura Substitutes, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 29
  • Table 15: Dura Substitutes, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 30
  • Table 16: Dura Substitutes, Brazil, Volume (Units), Historic, 2004-2011 31
  • Table 17: Dura Substitutes, Brazil, Volume (Units), Forecast, 2011-2018 32
  • Table 18: Dura Substitutes, Brazil, Average Price ($), Historic, 2004-2011 33
  • Table 19: Dura Substitutes, Brazil, Average Price ($), Forecast, 2011-2018 33
  • Table 20: CSF Management, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 34
  • Table 21: CSF Management, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 36
  • Table 22: CSF Management, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 37
  • Table 23: CSF Management, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 39
  • Table 24: CSF Management, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 41
  • Table 25: Hydrocephalus Shunts, Russian Federation, Revenue ($m, USD Constant, Historic, 2004-2011 43
  • Table 26: Hydrocephalus Shunts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 44
  • Table 27: Hydrocephalus Shunts, Russian Federation, Volume (Units), Historic, 2004-2011 45
  • Table 28: Hydrocephalus Shunts, Russian Federation, Volume (Units), Forecast, 2011-2018 46
  • Table 29: Hydrocephalus Shunts, Russian Federation, Average Price ($), Historic, 2004-2011 47
  • Table 30: Hydrocephalus Shunts, Russian Federation, Average Price ($), Forecast, 2011-2018 47
  • Table 31: Dura Substitutes, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 48
  • Table 32: Dura Substitutes, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 49
  • Table 33: Dura Substitutes, Russian Federation, Volume (Units), Historic, 2004-2011 50
  • Table 34: Dura Substitutes, Russian Federation, Volume (Units), Forecast, 2011-2018 51
  • Table 35: Dura Substitutes, Russian Federation, Average Price ($), Historic, 2004-2011 52
  • Table 36: Dura Substitutes, Russian Federation, Average Price ($), Forecast, 2011-2018 52
  • Table 37: CSF Management, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011 53
  • Table 38: CSF Management, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011 55
  • Table 39: CSF Management, India, Overall Revenue ($m), USD Constant, 2004-2018 56
  • Table 40: CSF Management, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 58
  • Table 41: CSF Management, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 60
  • Table 42: Hydrocephalus Shunts, India, Revenue ($m), USD Constant, Historic, 2004-2011 61
  • Table 43: Hydrocephalus Shunts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 62
  • Table 44: Hydrocephalus Shunts, India, Volume (Units), Historic, 2004-2011 63
  • Table 45: Hydrocephalus Shunts, India, Volume (Units), Forecast, 2011-2018 64
  • Table 46: Hydrocephalus Shunts, India, Average Price ($), Historic, 2004-2011 65
  • Table 47: Hydrocephalus Shunts, India, Average Price ($), Forecast, 2011-2018 65
  • Table 48: Dura Substitutes, India, Revenue ($m), USD Constant, Historic, 2004-2011 66
  • Table 49: Dura Substitutes, India, Revenue ($m), USD Constant, Forecast, 2011-2018 67
  • Table 50: Dura Substitutes, India, Volume (Units), Historic, 2004-2011 68
  • Table 51: Dura Substitutes, India, Volume (Units), Forecast, 2011-2018 69
  • Table 52: Dura Substitutes, India, Average Price ($), Historic, 2004-2011 70
  • Table 53: Dura Substitutes, India, Average Price ($), Forecast, 2011-2018 70
  • Table 54: CSF Management, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71
  • Table 55: CSF Management, India, Company Share by Revenue ($m), USD Constant, 2010-2011 73
  • Table 56: CSF Management, China, Overall Revenue ($m), USD Constant, 2004-2018 74
  • Table 57: CSF Management, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 76
  • Table 58: CSF Management, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 78
  • Table 59: Dura Substitutes, China, Revenue ($m), USD Constant, Historic, 2004-2011 79
  • Table 60: Dura Substitutes, China, Revenue ($m), USD Constant, Forecast, 2011-2018 80
  • Table 61: Dura Substitutes, China, Volume (Units), Historic, 2004-2011 81
  • Table 62: Dura Substitutes, China, Volume (Units), Forecast, 2011-2018 82
  • Table 63: Dura Substitutes, China, Average Price ($), Historic, 2004-2011 83
  • Table 64: Dura Substitutes, China, Average Price ($), Forecast, 2011-2018 83
  • Table 65: Hydrocephalus Shunts, China, Revenue ($m), USD Constant, Historic, 2004-2011 84
  • Table 66: Hydrocephalus Shunts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 85
  • Table 67: Hydrocephalus Shunts, China, Volume (Units), Historic, 2004-2011 86
  • Table 68: Hydrocephalus Shunts, China, Volume (Units), Forecast, 2011-2018 87
  • Table 69: Hydrocephalus Shunts, China, Average Price ($), Historic, 2004-2011 88
  • Table 70: Hydrocephalus Shunts, China, Average Price ($), Forecast, 2011-2018 88
  • Table 71: CSF Management, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 89
  • Table 72: CSF Management, China, Company Share by Revenue ($m), USD Constant, 2010-2011 91
  • Table 73: CSF Management, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 92
  • Table 74: CSF Management, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 94
  • Table 75: CSF Management, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 96
  • Table 76: Hydrocephalus Shunts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 97
  • Table 77: Hydrocephalus Shunts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 98
  • Table 78: Hydrocephalus Shunts, South Africa, Volume (Units), Historic, 2004-2011 99
  • Table 79: Hydrocephalus Shunts, South Africa, Volume (Units), Forecast, 2011-2018 100
  • Table 80: Hydrocephalus Shunts, South Africa, Average Price ($), Historic, 2004-2011 101
  • Table 81: Hydrocephalus Shunts, South Africa, Average Price ($), Forecast, 2011-2018 101
  • Table 82: Dura Substitutes, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 102
  • Table 83: Dura Substitutes, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 103
  • Table 84: Dura Substitutes, South Africa, Volume (Units), Historic, 2004-2011 104
  • Table 85: Dura Substitutes, South Africa, Volume (Units), Forecast, 2011-2018 105
  • Table 86: Dura Substitutes, South Africa, Average Price ($), Historic, 2004-2011 106
  • Table 87: Dura Substitutes, South Africa, Average Price ($), Forecast, 2011-2018 106
  • Table 88: CSF Management, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 107
  • Table 89: CSF Management, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 108
  • Table 90: Medtronic, Inc., Revenue ($m), BRICS CSF Management Market, 2011 110
  • Table 91: DePuy, Inc., Revenue ($m), BRICS CSF Management Market, 2011 112
  • Table 92: B. Braun Melsungen AG, Revenue ($m), BRICS CSF Management Market, 2011 114
  • Table 93: Integra LifeSciences Holdings Corporation, Revenue ($m), BRICS CSF Management Market, 2011 116
  • Table 94: Sophysa S.A., Revenue ($m), BRICS CSF Management Market, 2011 118
  • Table 95: Christoph Miethke GmbH & Co. KG, Revenue ($m), BRICS CSF Management Market, 2011 120
  • Table 96: G. Surgiwear Limited, Revenue ($m), BRICS CSF Management Market, 2011 121

List of Figures

1.2 List of Figures

  • Figure 1: CSF Management, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 12
  • Figure 2: CSF Management, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 13
  • Figure 3: CSF Management, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 15
  • Figure 4: CSF Management, BRICS, Company share (%), 2011 17
  • Figure 5: CSF Management, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 19
  • Figure 6: CSF Management, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20
  • Figure 7: CSF Management, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22
  • Figure 8: Hydrocephalus Shunts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 24
  • Figure 9: Hydrocephalus Shunts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 25
  • Figure 10: Hydrocephalus Shunts, Brazil, Volume (Units), Historic, 2004-2011 26
  • Figure 11: Hydrocephalus Shunts, Brazil, Volume (Units), Forecast, 2011-2018 27
  • Figure 12: Dura Substitutes, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 29
  • Figure 13: Dura Substitutes, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 30
  • Figure 14: Dura Substitutes, Brazil, Volume (Units), Historic, 2004-2011 31
  • Figure 15: Dura Substitutes, Brazil, Volume (Units), Forecast, 2011-2018 32
  • Figure 16: CSF Management, Brazil, Company Share (%), 2011 35
  • Figure 17: CSF Management, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 37
  • Figure 18: CSF Management, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 38
  • Figure 19: CSF Management, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 40
  • Figure 20: Hydrocephalus Shunts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 42
  • Figure 21: Hydrocephalus Shunts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 44
  • Figure 22: Hydrocephalus Shunts, Russian Federation, Volume (Units), Historic, 2004-2011 45
  • Figure 23: Hydrocephalus Shunts, Russian Federation, Volume (Units), Forecast, 2011-2018 46
  • Figure 24: Dura Substitutes, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 48
  • Figure 25: Dura Substitutes, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 49
  • Figure 26: Dura Substitutes, Russian Federation, Volume (Units), Historic, 2004-2011 50
  • Figure 27: Dura Substitutes, Russian Federation, Volume (Units), Forecast, 2011-2018 51
  • Figure 28: CSF Management, Russian Federation, Company Share (%), 2011 54
  • Figure 29: CSF Management, India, Overall Revenue ($m), USD Constant, 2004-2018 56
  • Figure 30: CSF Management, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 57
  • Figure 31: CSF Management, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 59
  • Figure 32: Hydrocephalus Shunts, India, Revenue ($m), USD Constant, Historic, 2004-2011 61
  • Figure 33: Hydrocephalus Shunts, India, Revenue ($m), USD Constant, Forecast, 2011-2018 62
  • Figure 34: Hydrocephalus Shunts, India, Volume (Units), Historic, 2004-2011 63
  • Figure 35: Hydrocephalus Shunts, India, Volume (Units), Forecast, 2011-2018 64
  • Figure 36: Dura Substitutes, India, Revenue ($m), USD Constant, Historic, 2004-2011 66
  • Figure 37: Dura Substitutes, India, Revenue ($m), USD Constant, Forecast, 2011-2018 67
  • Figure 38: Dura Substitutes, India, Volume (Units), Historic, 2004-2011 68
  • Figure 39: Dura Substitutes, India, Volume (Units), Forecast, 2011-2018 69
  • Figure 40: CSF Management, India, Company Share (%), 2011 72
  • Figure 41: CSF Management, China, Overall Revenue ($m), USD Constant, 2004-2018 74
  • Figure 42: CSF Management, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 75
  • Figure 43: CSF Management, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 77
  • Figure 44: Dura Substitutes, China, Revenue ($m), USD Constant, Historic, 2004-2011 79
  • Figure 45: Dura Substitutes, China, Revenue ($m), USD Constant, Forecast, 2011-2018 80
  • Figure 46: Dura Substitutes, China, Volume (Units), Historic, 2004-2011 81
  • Figure 47: Dura Substitutes, China, Volume (Units), Forecast, 2011-2018 82
  • Figure 48: Hydrocephalus Shunts, China, Revenue ($m), USD Constant, Historic, 2004-2011 84
  • Figure 49: Hydrocephalus Shunts, China, Revenue ($m), USD Constant, Forecast, 2011-2018 85
  • Figure 50: Hydrocephalus Shunts, China, Volume (Units), Historic, 2004-2011 86
  • Figure 51: Hydrocephalus Shunts, China, Volume (Units), Forecast, 2011-2018 87
  • Figure 52: CSF Management, China, Company Share (%), 2011 90
  • Figure 53: CSF Management, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 92
  • Figure 54: CSF Management, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 93
  • Figure 55: CSF Management, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 95
  • Figure 56: Hydrocephalus Shunts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 97
  • Figure 57: Hydrocephalus Shunts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 98
  • Figure 58: Hydrocephalus Shunts, South Africa, Volume (Units), Historic, 2004-2011 99
  • Figure 59: Hydrocephalus Shunts, South Africa, Volume (Units), Forecast, 2011-2018 100
  • Figure 60: Dura Substitutes, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 102
  • Figure 61: Dura Substitutes, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 103
  • Figure 62: Dura Substitutes, South Africa, Volume (Units), Historic, 2004-2011 104
  • Figure 63: Dura Substitutes, South Africa, Volume (Units), Forecast, 2011-2018 105
  • Figure 64: CSF Management, South Africa, Company Share (%), 2011 108
  • Figure 65: Medtronic, Inc., Company Share (%), BRICS CSF Management Market, 2011 110
  • Figure 66: DePuy, Inc., Company Share (%), BRICS CSF Management Market, 2011 112
  • Figure 67: B. Braun Melsungen AG, Company Share (%), BRICS CSF Management Market, 2011 114
  • Figure 68: Integra LifeSciences Holdings Corporation, Company Share (%), BRICS CSF Management Market, 2011 116
  • Figure 69: Sophysa S.A., Company Share (%), BRICS CSF Management Market, 2011 118
  • Figure 70: Christoph Miethke GmbH & Co. KG, Company Share (%), BRICS CSF Management Market, 2011 120
Show More
Pricing